Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 925 in its research report dated May 24, 2024.
Max Healthcare Institute Ltd on Wednesday reported a 2.81 per cent decline in profit after tax at Rs 311 crore in the fourth quarter ended March 31, 2024. The company had posted a Profit After Tax (PAT) of Rs 320 crore in the same quarter of the previous fiscal, Max Healthcare Institute said in a statement.